Ulrike Schröder

Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections

Ulrike Schröder, Bernhard A. Sabel · Brain Research · 1996 · 142 citations

Nanoparticles, Nanomedicine, Drug Carrier System +12

Influence of olfactory bulbectomy and subsequent imipramine treatment on 5‐hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates

Gisela Grecksch, Dan Zhou, Christian Franke et al. · British Journal of Pharmacology · 1997 · 72 citations

A New Rotane Family:  Synthesis, Structure, Conformation, and Dynamics of [3.4]-, [4.4]-, [5.4]-, and [6.4]Rotane¹

Lutz Fitjer, Christoph Steeneck, Said Gaini-Rahimi et al. · Journal of the American Chemical Society · 1998 · 22 citations

Materials Science, New Rotane Family, Search Routine Hunter +11

Synthesis, Hydrolytic Activation and Cytotoxicity of Etoposide Prodrugs

Wolf Wrasidlo, Ulrike Schröder, Kathrin M. Bernt et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 20 citations

Medicinal Chemistry, Etoposide Prodrugs, Pharmaceutical Science +4

Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.

Ulrike Schröder, Helmut Schröder, Wolfgang Augustin et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 17 citations